Autoimmune diseases induced by TNF-targeted therapies
M Ramos-Casals, P Brito-Zerón, MJ Soto… - Best practice & research …, 2008 - Elsevier
Anti-TNF agents are increasingly being used for a rapidly expanding number of rheumatic
and systemic autoimmune diseases. As a result of this use, and of the longer follow-up …
and systemic autoimmune diseases. As a result of this use, and of the longer follow-up …
Autoimmune diseases induced by biological agents: a double-edged sword?
M Ramos-Casals, C Diaz-Lagares, MJ Cuadrado… - Autoimmunity …, 2010 - Elsevier
Biological agents are increasingly used for a rapidly-expanding number of rheumatic and
systemic autoimmune diseases, with a growing number of reports of the paradoxical …
systemic autoimmune diseases, with a growing number of reports of the paradoxical …
Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature
Few studies have evaluated the impact of viral infections on the daily management of
patients with systemic lupus erythematosus (SLE). We analyzed the etiology and clinical …
patients with systemic lupus erythematosus (SLE). We analyzed the etiology and clinical …
[HTML][HTML] The management of thrombosis in the antiphospholipid-antibody syndrome
MA Khamashta, MJ Cuadrado, F Mujic… - … England Journal of …, 1995 - Mass Medical Soc
Background The antiphospholipid-antibody syndrome is a thrombophilic disorder in which
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid …
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid …
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria
M Barbhaiya, S Zuily, R Naden, A Hendry… - Arthritis & …, 2023 - Wiley Online Library
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …
specificity for use in observational studies and trials, jointly supported by the American …
EULAR recommendations for the management of antiphospholipid syndrome in adults
MG Tektonidou, L Andreoli, M Limper… - Annals of the …, 2019 - ard.bmj.com
The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …
Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases
M Ramos-Casals, P Brito-Zerón, S Muñoz, N Soria… - Medicine, 2007 - journals.lww.com
Tumor necrosis factor (TNF)-targeted therapies are increasingly used for a rapidly
expanding number of rheumatic and autoimmune diseases. With this use and longer follow …
expanding number of rheumatic and autoimmune diseases. With this use and longer follow …
Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF‐κB …
C López‐Pedrera, P Buendía… - … : Official Journal of …, 2006 - Wiley Online Library
Objective Antiphospholipid syndrome (APS) is characterized by thrombosis and the
presence of antiphospholipid antibodies (aPL). In patients with primary APS, expression of …
presence of antiphospholipid antibodies (aPL). In patients with primary APS, expression of …
Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression
MJ Cuadrado, C López‐Pedrera… - … : Official Journal of …, 1997 - Wiley Online Library
Objective. The antiphospholipid syndrome (APS) is a disorder of recurrent thrombosis,
pregnancy loss, and thrombocytopenia associated with the production of anticardiolipin …
pregnancy loss, and thrombocytopenia associated with the production of anticardiolipin …
The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review
S Sciascia, G Sanna, MA Khamashta… - Annals of the …, 2015 - ard.bmj.com
Background Around 10% of all thrombotic cerebrovascular events (CVE) occur in young
population and in a large proportion of those the trigger remains undetermined …
population and in a large proportion of those the trigger remains undetermined …